CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment

Clinical trial NCT07366112 · RECRUITING

Trial details

NCT number: NCT07366112
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Receptor-Positive Breast Cancer High-risk Breast Cancer Early-Stage Breast Cancer HER2-negative Breast Cancer ctDNA Monitoring

Start date: 2026-04-20
Primary completion: 2028-01-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.